Christie Medical Holdings

What Christie Medical Holdings does

Christie Medical Holdings, Inc. (formerly Luminetx Corporation), founded in 2004 and headquartered in Sanford, Florida, develops and commercializes the VeinViewer line of near-infrared (NIR) vascular imaging devices. The company's core technology uses harmless NIR light combined with Digital Light Processing (DLP) projection — leveraging Christie Digital Systems' 80+ years of projection engineering expertise — to project real-time HD digital images of subcutaneous vasculature directly onto the skin surface. The proprietary AVIN (Active Vascular Imaging Navigation) technology provides pre-, during-, and post-access visualization, while TrueView technology claims 3-10x greater accuracy than competitors (within 0.5mm average, +/-0.06mm for common peripheral IV veins). The product portfolio includes three hardware tiers: VeinViewer Vision2 (sixth-generation flagship with hands-free cart for hospital-wide use), VeinViewer VisionXTND (semi-permanent mount), and VeinViewer Flex (fifth-generation handheld portable device for non-acute markets).

Christie Medical serves healthcare providers across acute care hospitals, pediatrics/NICU, oncology, emergency departments, EMS, blood and plasma centers, aesthetics practices, and home healthcare, with named deployments including Baylor Scott & White (15 Texas facilities, 60+ units), St. Elizabeth Healthcare (six facilities), and Wolfson Children's Hospital (17 units). The company reports presence in 75% of U.S. News & World Report Honor Roll hospitals and operates in 40+ countries via direct sales in North America and 35+ distribution partners internationally (CAREstream America, IDSMed, Al Zahrawi, Abela Africa, Medilogic, Greiner Bio-One, DO-PA). Revenue is generated through one-time hardware device sales and the Christie Assure Program — a five-year subscription-style service commitment bundling utilization training, warranty, clinical education, and technology upgrade path. The company is a wholly-owned subsidiary of Christie Digital Systems, Inc., which is itself a subsidiary of Ushio, Inc. (Japan, JP:6925), and operates with 101-250 employees across U.S. and Canadian offices.

Name

Christie Medical Holdings

Legal name

Christie Medical Holdings, Inc.

Website

https://christiemed.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

Christie Medical Holdings develops and commercializes the VeinViewer line of near-infrared vascular imaging devices that project real-time HD images of subcutaneous vasculature onto skin, serving hospitals, EMS, blood/plasma centers, and home healthcare across 40+ countries via direct sales and a global distributor network.

Ownership category

akta.pro rank

Product category

Medical Imaging Devices (Vascular Imaging)

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)

Keywords

• Vein illumination devices
• Vascular imaging technology
• Near-infrared medical devices
• Vascular access visualization
• Infusion therapy equipment

Headquarters

HQ city

Lake Mary

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. VeinViewer Device Sales: Sale of VeinViewer vein illumination devices including VeinViewer Vision2 (hospital-wide use), VeinViewer Flex (handheld/portable), and VeinViewer VisionXTND (semi-permanent mount). Sold through direct sales and global distributor network in 40+ countries.
2. Christie Assure Program: Five-year comprehensive service program including utilization training, clinical education, warranty, and technology upgrade path. Provides recurring revenue through service contracts associated with device sales.
3. FreshStart Competitive Trade-In Program: Program allowing customers to trade in competitive vascular access visualization devices and receive credit toward VeinViewer purchase.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Christie Medical Holdings designs, manufactures, and sells the VeinViewer line of near-infrared vascular imaging devices (Vision2, Flex, VisionXTND) that use harmless NIR light combined with DLP projection technology to display real-time HD images of subcutaneous vasculature directly onto a patient's skin. The hardware is paired with proprietary ASSESS Plus imaging software, AVIN navigation, TrueView accuracy, and CathCompass catheter-sizing tools, and is backed by the multi-year Christie Assure Program covering training, warranty, education, and upgrade path.

Product overview

Christie Medical Holdings offers a portfolio of VeinViewer near-infrared vascular imaging devices designed to project real-time HD images of subcutaneous vasculature onto the skin surface. The product line includes three hardware tiers: VeinViewer Vision2 (6th generation flagship with MaxReach for hospital-wide use), VeinViewer VisionXTND (semi-permanent mount for single-seat procedures), and VeinViewer Flex (5th generation hand-held portable for non-acute markets). Supporting the hardware is the proprietary ASSESS/ASSESS Plus Imaging Suite providing multiple visualization modes, AVIN technology for Pre-, During-, Post-access navigation, TrueView accuracy technology, and DF2 digital full field projection. The company backs its products with the five-year Christie Assure Program (training, warranty, education, upgrades) and FreshStart trade-in program.

Differentiator

Problem solved

Functional benefit

Brands

• VeinViewer: Near-infrared vascular imaging system that projects real-time HD digital image of subcutaneous vasculature directly onto the skin surface. Available in multiple models including VeinViewer Vision2 and VeinViewer Flex.

Products and services

• VeinViewer Vision2 Sixth-generation flagship vein illumination device using NIR light and DLP projection to display real-time HD images of subcutaneous vasculature directly onto the skin; designed for hospital-wide deployment with hands-free cart-based operation, customizable color selection, and an 83% longer MaxReach for head-to-toe assessment. Targets acute care hospitals including ER, ICU, oncology, pediatrics, NICU, and radiology departments.
• VeinViewer Flex Fifth-generation handheld, portable vein illumination device designed for durability and portability in non-acute settings; features TrueView accuracy and optional MaxBright 40% brightness boost. Deployed in physician offices, blood and plasma centers, EMS, and home healthcare agencies for IV access and difficult venous access cases.
• VeinViewer VisionXTND Semi-permanent mount configuration of the VeinViewer, optimal for single-seat procedures where the patient comes to the clinician. Part of the three-tier VeinViewer product portfolio addressing different healthcare market segments.
• Christie Assure Program Industry-first five-year comprehensive service program bundled with VeinViewer devices, including utilization training by Clinical Applications Consultants, five-year warranty, ongoing clinical education for hospital staff, and a five-year technology upgrade path to the latest VeinViewer platforms. Provides recurring revenue through annual service contracts.

Quantifiable outcome

• Up to 100% increase in first stick success rate
• +5 more outcomes

Named customers11 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

14 partnerships are on record, tiered core and minor.

• B. Braun Medical Inc.coreStrategic or Co-development Partner · 27 April 2017Alliance between Christie Medical Holdings (market-leading vein finder technology) and B. Braun Medical Inc. (leader in infusion therapy and pain management) aimed at improving peripheral IV access success. B. Braun featured as event partner at INS conferences. Collaboration targets improved patient outcomes in vascular access.
• AttainiaminorChannel Partner/ Reseller/ Distributor · 23 June 2015Partnership to make VeinViewer product information available to users of Attainia's cloud-based healthcare equipment planning software solutions. Targets hospital procurement during capital equipment planning.
• NovationcoreGTM or Marketing Partner · 1 October 2013Christie VeinViewer awarded Innovative Technology designation from Novation, serving 100,000+ members of VHA Inc., UHC, Children's Hospital Association, and Provista. Designation makes VeinViewer easily identifiable in Novation's online contract catalog.
• Children's Miracle Network HospitalsminorOthers · 3 June 2011Donated 10 VeinViewer devices to Children's Miracle Network Hospitals as part of Walmart's annual in-store fundraising campaign. Top 10 Walmart and Sam's Club stores that raise the most funds receive a VeinViewer device for their local CMN Hospital.
• Al ZahrawicoreChannel Partner/ Reseller/ DistributorAuthorized partner for UAE distribution of VeinViewer Vision2 and VeinViewer Flex products. Al Zahrawi represents Christie at regional conferences including 2nd Emirates Critical Care Conference 2024.
• DO-PA A.S.coreChannel Partner/ Reseller/ DistributorTurkey distribution partner for VeinViewer products. Provides local sales and support for Christie products in Turkish healthcare market.
• CAREstream AmericacoreChannel Partner/ Reseller/ DistributorPrimary North American distributor partner for Christie Medical. CAREstream America represents VeinViewer at major U.S. healthcare conferences including MCEP, Wisconsin EMS Association, American Academy of Cosmetic Surgery, Baker Gordon, South Beach Symposium, and many others. Multiple booth presences at aesthetic, EMS, and cosmetic surgery events.
• IDSMedcoreChannel Partner/ Reseller/ DistributorSoutheast Asia and Indonesia distributor partner. IDSMed represents Christie at regional events including Indonesian PICU NICU Update, Konas Perdatin, and other Indonesian healthcare conferences. Primary partner for market development in Indonesia and Southeast Asia.
• Greiner Bio-One InternationalcoreGTM or Marketing PartnerHosted VeinViewer-focused webinar on November 3, 2021, featuring Christie VP Sarah Chapman on clinical applications in pediatrics, blood donation, and aesthetics. Strategic marketing partnership for educational content distribution.
• Abela AfricacoreChannel Partner/ Reseller/ DistributorSouth Africa distribution partner representing VeinViewer at regional conferences including Innovation In Anesthesia Symposium 2024, SIOP Africa 2024, All Africa Anesthesia (SASA) Congress 2024, and CCSSA Congress 2024.
• MedilogiccoreChannel Partner/ Reseller/ DistributorAustralia distributor partner. Featured at Day Hospitals Australia National Conference 2024 with booth presence.
• GreinerminorChannel Partner/ Reseller/ DistributorUK/Ireland distributor partner. Represented at National Infusion and Vascular Access Society 2024 and IV Summit 2024.
• Canadian Hospital SpecialtiesminorChannel Partner/ Reseller/ DistributorEvent partner representing Christie at Biomedical Engineering Society 2026 Annual Meeting.
• Vannie E. Cook Jr. Children's Cancer and Hematology ClinicminorOthersChristie CARES program donated three VeinViewer devices to the clinic as part of philanthropy initiative. Honored leukemia patient Daniela Villarreal who previously led fundraising campaign for VeinViewer at the clinic.

Scale indicators11 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• AccuVein: AccuVein is the closest direct competitor to Christie's VeinViewer, manufacturing handheld near-infrared vein visualization devices (AV400/AV500) for hospital, EMS, and aesthetic use. Same technology category, same clinical use cases (peripheral IV access, difficult venous access), and overlapping customer segments make it the most directly comparable peer.
• VueTek Scientific: VueTek Scientific produces VeinViewer competitor devices (e.g., AimVein) targeting hospital vascular access and phlebotomy markets. Operates in the same NIR vascular imaging category with comparable portable and handheld form factors for the same end-users.

Broad incumbents

• B. Braun Medical: B. Braun is a global leader in infusion therapy, IV access consumables, and pain management, with a formal strategic alliance with Christie Medical to recommend VeinViewer alongside its peripheral IV products. Operates broadly across vascular access but as part of a much wider medical products portfolio rather than specializing in visualization.
• Becton Dickinson (BD): BD is a major broad-line medical device incumbent whose Vascular Access Management unit (formerly BD Medical) sells PICC lines, midlines, and ultrasound-guided IV placement systems that compete for hospital vascular access budgets against VeinViewer's NIR modality. Comparable customer base (acute hospitals, vascular access teams) but broader product portfolio.
• ICU Medical: ICU Medical is a larger medical device manufacturer focused on IV therapy, critical care, and oncology infusion delivery. After acquiring Smiths Medical, it expanded into vascular access and syringe products that compete at the hospital IV workflow level where VeinViewer is positioned as a peripheral access enabler.
• Teleflex: Teleflex manufactures vascular access devices (Arrow brand PICC and central lines), intraosseous infusion, and related products serving the same hospital vascular access teams that adopt VeinViewer. A broad incumbent in procedural vascular care rather than a dedicated visualization specialist.
• GE HealthCare: GE HealthCare sells point-of-care ultrasound (Venue, Vscan) used as an alternative modality for vessel visualization during peripheral and central venous access. Operates broadly in imaging across hospital departments and is a competitor at the hospital capital purchase decision point, though its strength is ultrasound rather than NIR.
• FUJIFILM Sonosite: FUJIFILM Sonosite is the dominant point-of-care ultrasound vendor, including for ultrasound-guided peripheral IV access in emergency departments and ICUs. Competes with VeinViewer for the same hospital vascular access use case but via a different modality (ultrasound vs. NIR projection).
• Philips Healthcare: Philips offers point-of-care ultrasound (Lumify, CX50) and broader patient monitoring solutions that compete for the same hospital capital budgets and vascular access workflow footprint. A broad incumbent in clinical imaging rather than a dedicated vein-visualization competitor.

Emerging players

• AngioDynamics: AngioDynamics manufactures vascular access products (BioFlo PICC lines, VenaSeal) and some capital equipment used in vascular procedures. While not a direct NIR visualization competitor, it competes for the same hospital vascular access budget allocations and peripheral access decisions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/veinviewer-127631960590741
• Instagraminstagram.com/christiemedical
• Xx.com/christiemed
• LinkedInlinkedin.com/company/christie-medical-holdings-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Christie Medical Holdings